Literature DB >> 22157821

VprBP binds full-length RAG1 and is required for B-cell development and V(D)J recombination fidelity.

Michele D Kassmeier1, Koushik Mondal, Victoria L Palmer, Prafulla Raval, Sushil Kumar, Greg A Perry, Dirk K Anderson, Pawel Ciborowski, Sarah Jackson, Yue Xiong, Patrick C Swanson.   

Abstract

The N-terminus of full-length RAG1, though dispensable for RAG1/2 cleavage activity, is required for efficient V(D)J recombination. This region supports RING E3 ubiquitin ligase activity in vitro, but whether full-length RAG1 functions as a single subunit or a multi-subunit E3 ligase in vivo is unclear. We show the multi-subunit cullin RING E3 ligase complex VprBP/DDB1/Cul4A/Roc1 associates with full-length RAG1 through VprBP. This complex is assembled into RAG protein-DNA complexes, and supports in-vitro ubiquitylation activity that is insensitive to RAG1 RING domain mutations. Conditional B lineage-specific VprBP disruption arrests B-cell development at the pro-B-to-pre-B cell transition, but this block is bypassed by expressing rearranged immunoglobulin transgenes. Mice with a conditional VprBP disruption show modest reduction of D-J(H) rearrangement, whereas V(H)-DJ(H) and V(κ)-J(κ) rearrangements are severely impaired. D-J(H) coding joints from VprBP-insufficent mice show longer junctional nucleotide insertions and a higher mutation frequency in D and J segments than normal. These data suggest full-length RAG1 recruits a cullin RING E3 ligase complex to ubiquitylate an unknown protein(s) to limit error-prone repair during V(D)J recombination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157821      PMCID: PMC3280554          DOI: 10.1038/emboj.2011.455

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Cytoplasmic retention of HIV-1 regulatory protein Vpr by protein-protein interaction with a novel human cytoplasmic protein VprBP.

Authors:  S Zhang; Y Feng; O Narayan; L J Zhao
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

2.  The RAG1 N-terminal domain is an E3 ubiquitin ligase.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Moshe Sadofsky
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

3.  The RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated, phosphorylated histone 3.3.

Authors:  Jessica M Jones; Anamika Bhattacharyya; Carrie Simkus; Brice Vallieres; Timothy D Veenstra; Ming Zhou
Journal:  Immunol Lett       Date:  2011-01-20       Impact factor: 3.685

4.  The Cullin-RING E3 ubiquitin ligase CRL4-DCAF1 complex dimerizes via a short helical region in DCAF1.

Authors:  Jinwoo Ahn; Zach Novince; Jason Concel; Chang-Hyeock Byeon; Alexander M Makhov; In-Ja L Byeon; Peijun Zhang; Angela M Gronenborn
Journal:  Biochemistry       Date:  2011-01-31       Impact factor: 3.162

Review 5.  V(D)J recombination: RAG proteins, repair factors, and regulation.

Authors:  Martin Gellert
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

6.  RAG2 is down-regulated by cytoplasmic sequestration and ubiquitin-dependent degradation.

Authors:  Ryushin Mizuta; Midori Mizuta; Shinsuke Araki; Daisuke Kitamura
Journal:  J Biol Chem       Date:  2002-08-29       Impact factor: 5.157

7.  Autoubiquitylation of the V(D)J recombinase protein RAG1.

Authors:  Jessica M Jones; Martin Gellert
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

8.  Pre-steady-state kinetic studies of the fidelity and mechanism of polymerization catalyzed by truncated human DNA polymerase lambda.

Authors:  Kevin A Fiala; Wissam Abdel-Gawad; Zucai Suo
Journal:  Biochemistry       Date:  2004-06-01       Impact factor: 3.162

9.  V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.

Authors:  A Villa; C Sobacchi; L D Notarangelo; F Bozzi; M Abinun; T G Abrahamsen; P D Arkwright; M Baniyash; E G Brooks; M E Conley; P Cortes; M Duse; A Fasth; A M Filipovich; A J Infante; A Jones; E Mazzolari; S M Muller; S Pasic; G Rechavi; M G Sacco; S Santagata; M L Schroeder; R Seger; D Strina; A Ugazio; J Väliaho; M Vihinen; L B Vogler; H Ochs; P Vezzoni; W Friedrich; K Schwarz
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

10.  Impaired V(D)J recombination and lymphocyte development in core RAG1-expressing mice.

Authors:  Darryll D Dudley; JoAnn Sekiguchi; Chengming Zhu; Moshe J Sadofsky; Scott Whitlow; Jeffrey DeVido; Robert J Monroe; Craig H Bassing; Frederick W Alt
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  21 in total

1.  A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation.

Authors:  Wei Wei; Haoran Guo; Xianjun Liu; Hong Zhang; Lei Qian; Kun Luo; Richard B Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

2.  VprBP Is Required for Efficient Editing and Selection of Igκ+ B Cells, but Is Dispensable for Igλ+ and Marginal Zone B Cell Maturation and Selection.

Authors:  Victoria L Palmer; Razia Aziz-Seible; Michele D Kassmeier; Mary Rothermund; Greg A Perry; Patrick C Swanson
Journal:  J Immunol       Date:  2015-07-06       Impact factor: 5.422

Review 3.  Histone methylation and V(D)J recombination.

Authors:  Noriko Shimazaki; Michael R Lieber
Journal:  Int J Hematol       Date:  2014-07-25       Impact factor: 2.490

4.  Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis.

Authors:  Johannes Waage; Marie Standl; John A Curtin; Leon E Jessen; Jonathan Thorsen; Chao Tian; Nathan Schoettler; Carlos Flores; Abdel Abdellaoui; Tarunveer S Ahluwalia; Alexessander C Alves; Andre F S Amaral; Josep M Antó; Andreas Arnold; Amalia Barreto-Luis; Hansjörg Baurecht; Catharina E M van Beijsterveldt; Eugene R Bleecker; Sílvia Bonàs-Guarch; Dorret I Boomsma; Susanne Brix; Supinda Bunyavanich; Esteban G Burchard; Zhanghua Chen; Ivan Curjuric; Adnan Custovic; Herman T den Dekker; Shyamali C Dharmage; Julia Dmitrieva; Liesbeth Duijts; Markus J Ege; W James Gauderman; Michel Georges; Christian Gieger; Frank Gilliland; Raquel Granell; Hongsheng Gui; Torben Hansen; Joachim Heinrich; John Henderson; Natalia Hernandez-Pacheco; Patrick Holt; Medea Imboden; Vincent W V Jaddoe; Marjo-Riitta Jarvelin; Deborah L Jarvis; Kamilla K Jensen; Ingileif Jónsdóttir; Michael Kabesch; Jaakko Kaprio; Ashish Kumar; Young-Ae Lee; Albert M Levin; Xingnan Li; Fabian Lorenzo-Diaz; Erik Melén; Josep M Mercader; Deborah A Meyers; Rachel Myers; Dan L Nicolae; Ellen A Nohr; Teemu Palviainen; Lavinia Paternoster; Craig E Pennell; Göran Pershagen; Maria Pino-Yanes; Nicole M Probst-Hensch; Franz Rüschendorf; Angela Simpson; Kari Stefansson; Jordi Sunyer; Gardar Sveinbjornsson; Elisabeth Thiering; Philip J Thompson; Maties Torrent; David Torrents; Joyce Y Tung; Carol A Wang; Stephan Weidinger; Scott Weiss; Gonneke Willemsen; L Keoki Williams; Carole Ober; David A Hinds; Manuel A Ferreira; Hans Bisgaard; David P Strachan; Klaus Bønnelykke
Journal:  Nat Genet       Date:  2018-07-16       Impact factor: 38.330

5.  Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences.

Authors:  Julie E Horowitz; Craig H Bassing
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

6.  The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA.

Authors:  Asif A Dar; Keisuke Sawada; Joseph M Dybas; Emily K Moser; Emma L Lewis; Eddie Park; Hossein Fazelinia; Lynn A Spruce; Hua Ding; Steven H Seeholzer; Paula M Oliver
Journal:  PLoS Biol       Date:  2021-02-01       Impact factor: 8.029

7.  Nucleolar localization of RAG1 modulates V(D)J recombination activity.

Authors:  Ryan M Brecht; Catherine C Liu; Helen A Beilinson; Alexandra Khitun; Sarah A Slavoff; David G Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-11       Impact factor: 11.205

8.  VprBP (DCAF1) Regulates RAG1 Expression Independently of Dicer by Mediating RAG1 Degradation.

Authors:  N Max Schabla; Greg A Perry; Victoria L Palmer; Patrick C Swanson
Journal:  J Immunol       Date:  2018-06-20       Impact factor: 5.422

Review 9.  Riches in RAGs: Revealing the V(D)J Recombinase through High-Resolution Structures.

Authors:  Karla K Rodgers
Journal:  Trends Biochem Sci       Date:  2016-11-05       Impact factor: 13.807

Review 10.  Molecular insights into NF2/Merlin tumor suppressor function.

Authors:  Jonathan Cooper; Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-04-12       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.